Pay in 4 interest-free payments of $18.75 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
R547 administered with oral and i
is an endothelin receptor antagonist and an pharmacologically active metabolite of macitentan
ONO5046-Na
Data from molecular docking and substrate competition assays established that the primary molecular target of VR23 was β2 of the 20S proteasome catalytic subunit
2016 Jan 12
Ranolazine none I R547 administered with oral andRanolazine is an anti ischemic compound, which inhibits late sodium current that results in a reduction of Na+ dependent Ca2+ overload. Studies indicate that ATP production is shifted towards glucose oxidation by Ranolazine. This is due to the fact that more oxygen is required to phosphorylate the same amount of ATP during fatty acid oxidation than carbohydrate oxidation. These studies indicate that Ranolazine also inhibits oxygen consumption and
US$ 254.50
US$ 169.50
US$ 200.00
US$ 203.00
US$ 167.00
US$ 132.00
US$ 44.00
US$ 153.50
US$ 306.50
US$ 144.00
US$ 199.50